hat
FDA apwouve Pregabalin (148553-50-8) pou tretman epilepsi. Se dwòg sa a rekòmande pou pasyan ki gen epilepsi yon pati nan akòz domajman nan sèvo. Li se tou itilize kòm yon terapi adjunctif pou moun ki lòt medikaman anti-malkadi te echwe pou pou travay.
eng
FDA approved Pregabalin (148553-50-8) for the treatment of epilepsy. This drug is recommended for patients with partial epilepsy due to brain injury. It is also used as an adjunctive therapy for people that other anti-epileptic medications have failed to work.